Yixintang

Yixintang Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Yixintang") was established on November 8, 2000. Over the past 20+ years since its inception, it has deeply cultivated Yunnan and expanded nationwide. As of September 30, 2024, Yixintang and its wholly-owned subsidiaries collectively own 11,516 directly-operated chain stores, with over 55 million effective members and serving 180 million customer visits annually. It has spread across 10 provinces and municipalities directly under the central government, including Yunnan, Guizhou, Guangxi, Hainan, Sichuan, Chongqing, Shanxi, Henan, Tianjin, and Shanghai. It is a nationally renowned and leading-scale listed pharmaceutical retail chain enterprise. Yixintang has now developed into a large health platform enterprise integrating pharmacy retail, biomedical, and medical-nursing services. Its main business covers: chain retail, commercial wholesale, R&D and production of traditional Chinese medicine, planting and processing of biological medicinal materials, as well as medical and elderly care industries. Yixintang has always adhered to the service purpose of "Dedicated to the people, wholehearted service," and insists on serving every consumer with "love, care, sincerity, meticulousness, and perseverance." In 2023, Yixintang achieved operating revenue of 17.38 billion yuan and paid taxes of 538 million yuan. In the first three quarters of 2024, Yixintang achieved operating revenue of 13.589 billion yuan, a year-on-year increase of 6.06%. The grand blueprint of the "Healthy China" strategy has been drawn. Guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, Yixintang maintains long-term strategic focus, faces challenges head-on, and strives for progress. Centered on customers, it adheres to the essence of service, embraces change and innovation, pursues excellence, stands at the forefront, and aims for new peaks!